Peter Radvák
Impact in
-
- Cancer, Hypoxia, and Metabolism
-
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
-
- Influenza Virus Research Studies 4
-
- Viral Infections and Vectors 1
- SARS-CoV-2 detection and testing 1
- Co-authors
- Silvia Pastoreková (5 shared papers)Lucia Csáderová (4 shared papers)Eliška Švastová (2 shared papers)Juraj Kopáček (2 shared papers)Hang Xie (6 shared papers)Martina Košíková (5 shared papers)Jaromı́r Pastorek (3 shared papers)Zhiping Ye (3 shared papers)
- Journals
- Clinical Infectious Diseases (2 papers)Scientific Reports (2 papers)npj Vaccines (1 paper)The Science of The Total Environment (1 paper)Oncotarget (1 paper)
- Partner nations
- SlovakiaUnited StatesCzechia
In The Last Decade
Peter Radvák
12 papers receiving 329 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 63
- Infectious Diseases 71
- Molecular Biology 174
- Immunology 48
- Epidemiology 57
Countries citing papers authored by Peter Radvák
This map shows the geographic impact of Peter Radvák's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Radvák with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Radvák more than expected).
Fields of papers citing papers by Peter Radvák
This network shows the impact of papers produced by Peter Radvák. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Radvák. The network helps show where Peter Radvák may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Radvák, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 79 | |
| 2 | 2021 | 61 | |
| 3 | 2013 | 44 | |
| 4 | 2018 | 41 | |
| 5 | 2017 | 40 | |
| 6 | 2016 | 26 | |
| 7 | 2022 | 13 | |
| 8 | 2022 | 12 | |
| 9 | 2020 | 6 | |
| 10 | 2021 | 5 | |
| 11 | 2019 | 4 | |
| 12 | 2024 | 1 | |
| 13 | 2023 | 0 |
About Peter Radvák
Peter Radvák is a scholar working on Epidemiology, Infectious Diseases, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 13 papers that have together received 332 indexed citations. Recurring topics across this work include Influenza Virus Research Studies (4 papers), Cancer, Hypoxia, and Metabolism (2 papers), Enzyme function and inhibition (2 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper), Lung Cancer Research Studies (1 paper), Viral Infections and Vectors (1 paper), SARS-CoV-2 detection and testing (1 paper) and Ion channel regulation and function (1 paper). The work is most often cited by research in Cancer Research (63 citations), Infectious Diseases (71 citations), Molecular Biology (174 citations), Immunology (48 citations) and Epidemiology (57 citations). Peter Radvák has collaborated with scholars based in Slovakia, United States and Czechia. Frequent co-authors include Silvia Pastoreková, Lucia Csáderová, Eliška Švastová, Juraj Kopáček, Hang Xie, Martina Košíková, Jaromı́r Pastorek, Zhiping Ye, Lei Li and Xiu‐Feng Wan. Their work appears in journals such as Clinical Infectious Diseases, Scientific Reports, npj Vaccines, The Science of The Total Environment and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.